Kelsey Ann Burns, OTR/L Occupational Therapist - Pediatrics Medicare: Medicare Enrolled Practice Location: 2060 Centre Pointe Blvd Ste 3, Mendota Heights, MN 55120 Phone: 615-275-6420 |
Cassandra Hagen Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1160 Centre Pointe Dr, Mendota Heights, MN 55120 Phone: 952-215-3754 |
Krista Marie Judge, MA OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2520 Pilot Knob Rd Ste 190, Mendota Heights, MN 55120 Phone: 952-223-2506 Fax: 952-443-2038 |
Roots To Wings, Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2354 Field Stone Ct, Mendota Heights, MN 55120 Phone: 651-206-1034 |
News Archive
Sonitor Technologies, Inc., a global leader in indoor positioning technologies, announced today the expansion of its industry-leading Sonitor Sense RTLS open integration platform.
Approximately 1 in 5 adults in the United States experience mental illness in a given year. Severe mental illnesses cause the brain to have trouble dealing with cognitively effortful states, like focusing attention over long periods of time, discriminating between two things that are difficult to tell apart, and responding quickly to information that is coming in fast.
We are very pleased that the court ruled in favor of the U.S. Departments of Labor, Treasury, and Health and Human Services, thereby allowing us to continue a regulatory process designed to benefit vulnerable members of our society. It will make mental health benefits more affordable by putting the cost on par with other health benefits.
A new class of cholesterol-lowering drug has been found to help patients cut their risk of cardiovascular disease, stroke and heart attack.
Silence Therapeutics plc announces that the Company and AstraZeneca have agreed to a one-year extension of their ongoing small interfering RNA (siRNA) delivery collaboration. Under this collaboration, which was originally entered into in March 2008, the companies are leveraging a number of Silence's proprietary lipid delivery and targeting technologies to develop new and enhanced delivery approaches for RNA interference (RNAi) therapeutics.
› Verified 3 days ago